SciVision Biotech

SciVision Biotech Enterprise Value

The Enterprise Value (EV) of SciVision Biotech (1786.TW) as of Oct 20, 2026 is 4.38 B TWD. In the previous year, Enterprise Value (EV) was 4.31 B TWD — a change of 1.81% (higher).

Enterprise Value

4.38 BTWD

YoY

1.81%

Last updated:

Enterprise Value (EV) of SciVision Biotech is 2025 4.38 B TWD. Enterprise Value (EV) of SciVision Biotech was 2024 4.31 B TWD. It decreases by 1.81% higher compared to the previous year.

The SciVision Biotech Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
4.93 B TWD
Jan 1, 2019
4.84 B TWD
Jan 1, 2020
4.86 B TWD
Jan 1, 2021
4.89 B TWD
Jan 1, 2022
4.69 B TWD
Jan 1, 2023
4.50 B TWD
Jan 1, 2024
4.31 B TWD
Jan 1, 2025
4.38 B TWD
The SciVision Biotech Enterprise Value history
YEAREnterprise ValueYoY
4.38 BTWD+1.81%
4.31 BTWD-4.25%
4.50 BTWD-4.14%
4.69 BTWD-4.07%
4.89 BTWD+0.61%
4.86 BTWD+0.51%
4.84 BTWD-1.93%
4.93 BTWD-3.41%
5.11 BTWD+6.59%
4.79 BTWD+5.44%
4.54 BTWD+6.96%
4.25 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SciVision Biotech Stock analysis

What does SciVision Biotech do? SciVision Biotech Inc, based in Kaohsiung, Taiwan, specializes in the research, development, and production of hyaluronic acid medical products. The company offers subcutaneous fillers for plastic surgery, joint cavity injections for orthopedics, and hyaluronic acid raw materials. It also provides DNA identification, detection, sequencing, and related applications, alongside care products and food manufacturing. SciVision Biotech operates globally across the Americas, Europe, Asia, the Middle East, and Africa. SciVision Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SciVision Biotech stock

Enterprise Value (EV) of SciVision Biotech is 4.38 B TWD in 2025.

Enterprise Value (EV) of SciVision Biotech changed from 4.31 B TWD to 4.38 B TWD, representing a 1.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) SciVision Biotech since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s SciVision Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — SciVision Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — SciVision Biotech